Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
enGene Therapeutics Inc.Listing on record | Buy | $19.7K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $38.8K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $64.7K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $2.2M | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $5.3K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $77.6K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $228.1K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $39.2K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $227.2K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $87.4K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $3.3K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $20.7K | SEC | |
enGene Therapeutics Inc.Listing on record | Buy | $37.4K | SEC | |
Forbion European Acquisition Corp.Listing unverified | OtherD (derivative) | — | SEC | |
Forbion European Acquisition Corp.Listing unverified | Other | — | SEC | |
Forbion European Acquisition Corp.Listing unverified | Other | — | SEC | |
Forbion European Acquisition Corp.Listing unverified | OtherD (derivative) | — | SEC |